Skip to main navigation Skip to search Skip to main content

Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection

  • Andrew Lim
  • , Afsana Amini
  • , Lloyd J. D'Orsogna
  • , Reena Rajasuriar
  • , Marit Kramski
  • , Sharon R. Lewin
  • , Damian F. Purcell
  • , Patricia Price
  • , Martyn A. French

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Objectives: To examine the relationship between plasma markers of microbial translocation and antibodies to lipopolysaccharide (LPS) and circulating memory B cells in patients with HIV infection. Design: Cross-sectional study in antiretroviral therapy (ART)-naive (n=23) and ART-treated (n=27) HIV patients. Methods: Antibodies to LPS and immunoglobulins, assayed in stored serum, and matched memory B-cell counts were correlated with levels of LPS and bacterial 16S ribosome DNA (16S rDNA), assayed in stored plasma. Results: In ART-naive patients, plasma LPS levels correlated inversely with serum levels of IgG and IgA antibodies to LPS (P=0.03 and 0.006, respectively), serum levels of IgA anti-LPS correlated with total IgA (P<0.0001) and levels of IgG anti-LPS correlated with IgM memory B-cell counts (P=0.025). In ART-treated patients, plasma LPS levels were not related to levels of LPS antibodies, but were related to CD4 T-cell and switched memory B-cell counts. There were no correlations with plasma levels of 16S rDNA. Conclusion: Plasma LPS levels were associated with antibody and possibly B-cell responses to LPS in ART-naive HIV patients, whereas they were associated with the degree of immune reconstitution in ART-treated patients.

Original languageEnglish
Pages (from-to)1379-1383
Number of pages5
JournalAIDS
Volume25
Issue number11
DOIs
StatePublished - 17 Jul 2011
Externally publishedYes

Keywords

  • HIV
  • IgA
  • lipopolysaccharide antibodies
  • memory B cells
  • microbial translocation

Fingerprint

Dive into the research topics of 'Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection'. Together they form a unique fingerprint.

Cite this